Angiotensin Receptor Blockers : Current Status and Future ProspectsRAM, C. Venkata S.The American journal of medicine. 2008, Vol 121, Num 8, pp 656-663, issn 0002-9343, 8 p.Article

Angiotensin II-receptor blocker dosages : How high should we go?DÜSING, R.International journal of clinical practice (Esher). 2006, Vol 60, Num 2, pp 179-183, issn 1368-5031, 5 p.Article

Increased Capillary Branching Contributes to Angiotensin Type 1 Receptor Blocker (ARB)―Induced Regression of SclerosisSCRUGGS, Benjamin S; YIQIN ZUO; DONNERT, Ellen et al.The American journal of pathology. 2011, Vol 178, Num 4, pp 1891-1898, issn 0002-9440, 8 p.Article

RENAL ISCHEMIA MODIFIED BY AN ANGIOTENSIN ANTAGONIST = MODIFICATION DE L'ISCHEMIE RENALE PAR UN ANTAGONISTE DE L'ANGIOTENSINEUEHLING D; HEBER D; GOODFRIEND TL et al.1974; INVEST. UROL.; U.S.A.; DA. 1974; VOL. 11; NO 5; PP. 345-346; BIBL. 13 REF.Article

LES INHIBITEURS COMPETITIFS DE L'ANGIOTENSINE IICHAMONTIN B; SALVADOR M; GUITTARD J et al.1980; THERAPIE; ISSN 0040-5957; FRA; DA. 1980; VOL. 35; NO 5; PP. 637-640; BIBL. 18 REF.Article

Twisting arms to angiotensin receptor blockers/antagonists: the turn of cancerVOLPE, Massimo; AZIZI, Michel; JAN DANSER, A. H et al.European heart journal. 2011, Vol 32, Num 1, pp 19-22, issn 0195-668X, 4 p.Article

Angiotensin II can induce and potentiate shape change in human platelets : effect of losartanJAGROOP, I. A; MIKHAILIDIS, D. P.Journal of human hypertension. 2000, Vol 14, Num 9, pp 581-585, issn 0950-9240Article

A cyclic angiotensin antagonist: [1,8-cysteine]angiotensin IIMATSOUKAS, J. M; SCANLON, M. N; MOORE, G. J et al.Journal of medicinal chemistry (Print). 1984, Vol 27, Num 3, pp 404-406, issn 0022-2623Article

High-Affinity Interaction of Sartans with H⁺/Peptide TransportersKNÜTTER, Ilka; KOTTRA, Gabor; FISCHER, Wiebke et al.Drug metabolism and disposition. 2009, Vol 37, Num 1, pp 143-149, issn 0090-9556, 7 p.Article

2nd international forum on angiotensin II receptor antagonism (Monte-Carlo, January 24-26 2001, abstracts)International forum on angiotensin II receptor antagonism. 2001, 44 p.Conference Proceedings

SYSTEMIC HEMODYNAMICS AND HORMONAL RESPONSES DURING ANGIOTENSIN II BLOCKADE WITH SARALASINROOS JC; GEYSKES GG; BOER P et al.1981; J. CARDIOVASC. PHARMACOL.; ISSN 0160-2446; USA; DA. 1981; VOL. 3; NO 5; PP. 1106-1115; BIBL. 28 REF.Article

THE INFLUENCE OF SARALA ANGIOTENSIN II (SARALASIN) ON PLASMA ALDOSTERONE IN HYPERTENSIVE PATIENTSDONKER AJM; VAN HOOGDALEM P; PRATT JJ et al.1979; ACTA MED. SCAND.; SWE; DA. 1979; VOL. 205; NO 3; PP. 207-212; BIBL. 21 REF.Article

INHIBITION OF THE RENIN-ANGIOTENSIN SYSTEM. A NEW APPROACH TO THE THERAPY OF HYPERTENSIONONDETTI MA; CUSHMAN DW.1981; J. MED. CHEM.; ISSN 0022-2623; USA; DA. 1981; VOL. 24; NO 4; PP. 355-361; BIBL. 61 REF.Article

ORGAN SELECTIVE ANGIOTENSIN ANTAGONISTS: SARCOSYL¹-CYSTEINYL (S-METHYL)⁸-ANGIOTENSIN IFREER RJ; SUTHERLAND JC JR; DAY AR et al.1980; EUROP. J. PHARMACOL.; NLD; DA. 1980; VOL. 65; NO 4; PP. 349-354; BIBL. 18 REF.Article

SARALASINA ED IPERTENSIONE ARTERIOSA A BASSA RENINEMIA = SARALASINE ET HYPERTENSION ARTERIELLE AVEC RENINEMIE BASSEFRISINA N; BUEMI M; LASCO A et al.1980; BOLL. SOC. ITAL. BIOL. SPER.; ITA; DA. 1980; VOL. 56; NO 13; PP. 1367-1373; ABS. ENG; BIBL. 14 REF.Article

Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertensionCALVINO, J; LENS, X. M; ROMERO, R et al.Nephrology, dialysis, transplantation (Print). 2000, Vol 15, Num 1, pp 82-86, issn 0931-0509Article

Vaisseaux, cœur et rein: l'angiotensine II toujours d'actualité: Agir avant l'accident: impact des antagonistes de l'angiotensine IIBONNET, J; OBREJA, D.Archives des maladies du coeur et des vaisseaux. Pratique. 2011, Num MARS, issn 1261-694X, S1-S3, SUP1Article

Angiotensin II receptor blockers for the treatment of heart failure : A class effect?HUDSON, Marie; HUMPHRIES, Karin; TU, Jack V et al.Pharmacotherapy. 2007, Vol 27, Num 4, pp 526-534, issn 0277-0008, 9 p.Article

Effect of losorlan on muscle sympathetic activity and baroreceptor function in systemic hypertensionBECHIR, Markus; ENSELEIT, Frank; CHENEVARD, Rémy et al.The American journal of cardiology. 2005, Vol 95, Num 1, pp 129-131, issn 0002-9149, 3 p.Article

Angiotensin II receptor antagonists: Role in hypertension, cardiovascular disease, and renoprotectionAPPEL, Gerald B; APPEL, Alice S.Progress in cardiovascular diseases. 2004, Vol 47, Num 2, pp 105-115, issn 0033-0620, 11 p.Article

les antagonistes des récepteurs de l'angiotensine II: différents ou équivalents? = Angiotensin II receptor antagonists: are they all the same ?MOUNIER-VEHIER, C; DEVOS, P.La Presse médicale (1983). 2001, Vol 30, Num 21, pp 1072-1075, issn 0755-4982Article

New Clinical Trials of Angiotensin Blockade in Cardiovascular DiseaseJULIUS, Stevo.American journal of hypertension. 2000, Vol 13, Num 5, issn 0895-7061, 30 p., 2Serial Issue

Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedemaWARNER, K. K; VISCONTI, J. A; TSCHAMPEL, M. M et al.The Annals of pharmacotherapy. 2000, Vol 34, Num 4, pp 526-528, issn 1060-0280Article

Angiotensin II antagonistsSMITH, R. D; CUNNINGHAM, G; KIVLIGHN, S. D et al.Emerging drugs. 1998, Vol 3, pp 81-93, issn 1361-9195Article

Angiotensin Receptor Blockers and Angiotensin- Converting Enzyme Inhibitors: Challenges in Comparative Effectiveness Using Medicare DataSETOGUCHI, S; SHRANK, W. H; LIU, J et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 5, pp 674-682, issn 0009-9236, 9 p.Article